Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. Par is a portfolio company of TPG, a leading global private investment firm with $55.7 billion of assets under management and with extensive experience in the healthcare sector.

The following is the list of scholars from PAR Sterile Products who currently serve as editors for one or more SciTechnol journals.

• Vinayagam Kannan, PhD

The following is the list of articles by scholars from PAR Sterile Products that are published in SciTechnol journals.

• A Contraindication is a Specific Situation in Which a Drug

  Editorial: J Pharm Drug Deliv Res
  DOI:
  
  
  • PDF

• A Prod Rug could also be a Medicine or Compound that, After Administration

  Editorial: J Pharm Drug Deliv Res
  DOI:
  
  
  • PDF

• Pharmacovigilance is now firmly based on sound scientific principles and is integral to effective clinical practice

  Commentary: J Pharm Drug Deliv Res
  DOI:
  
  
  • PDF

• Drug Delivery Systems are Engineered Technologies for the Targeted Delivery and Controlled Release

  Commentary: J Pharm Drug Deliv Res
  DOI:
  
  
  • PDF

• Over all View of Viral Infections and their Therapeutic Management In Covid-19 Pandemic

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Richard H
  
  • Abstract
  • PDF

• Recent Advancements in the Diagnosis, Prevention of Drug Therapy-COVID-19

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Kumud Joshi
  
  • Abstract
  • PDF

• COVID-19 and Black Fungus: What Is Mucormycosis?

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Prudvi Raj
  
  • Abstract
  • PDF

• Covid-19: India Sees Record Deaths as “Black Fungus” Spreads Fear

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Anjali Gupta
  
  • PDF

• Bioavailability Hinders Drug Discovery Against Covid-19, Guided By In Silico Docking

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Simone Cristina
  
  • Abstract
  • PDF

• Everyday Lifestyle with Nanotechnology

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Patrick Jane
  
  • Full-text
  • PDF

• Branches of Pharmaceutics and the Novel Drug Delivery Systems

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Lisbon Teresa
  
  • Full-text
  • PDF

• Pharmacotherapy and Psychotherapy Medication Adherence

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Cho Rigsby
  
  • Full-text
  • PDF

• Molecular Drug Design and Rational Design of a Targeted Drug site

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Grace Vampelt
  
  • Full-text
  • PDF

• Drug Discovery and Improvement in the Development of New Therapeutic Drug Substance

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Ross Geller
  
  • Full-text
  • PDF

• A Comparison among Three Skin Preparations for the Transdermal Delivery of Vitamin B12 by Iontophoresis: A Novel Approach to Determine Systemic Absorption

  Research Article: J Pharm Drug Deliv Res
  DOI:
  Anton V Sabiev, Mark A Korsten, and William A Bauman
  
  • Abstract
  • Full-text
  • PDF

• Nano Based Drug Delivery Systems

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Peter K
  
  • PDF

• Applications of Bio Pharmaceutics

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Kok Kwang
  
  • PDF

• Impacts on Drug Delivery Systems

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Andrew J. Clulow
  
  • PDF

• Statistics of Drug Safety Databases

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Yeonju Woo
  
  • PDF

• Industrial Pharmacy for Better Enrichment

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Xin Di
  
  • PDF

• Advantages of Molecular Drug Design

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Asad U.Khan
  
  • PDF

• Drug Targeting

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Christo Cimino
  
  • PDF

• Over All View of Industrial Pharmacy

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Joseph
  
  • Abstract
  • PDF

• Drug design

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Kuang*
  
  • Abstract
  • PDF

• Contraindications and their Advancements

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Susant Nayak*
  
  • PDF

• Carriers for Prodrug Synthesis

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Peter James
  
  • Abstract
  • PDF

• Bio-pharmaceutics Drug Disposition

  Commentary: J Pharm Drug Deliv Res
  DOI:
  William James
  
  • Abstract
  • PDF

• Medical Diagnosis

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Jun Ye
  
  • Abstract
  • PDF

• Drug Absorption

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Peter James
  
  • PDF

• Drug Delivery has Lately Become an Important Route of Drug Administration

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Silva Saints
  
  • Abstract
  • Full-text
  • PDF

• Quality Testing Involves Each Step of the Manufacturing Recess

  Editorial: J Pharm Drug Deliv Res
  DOI:
  Haisheng Peng
  
  • Abstract
  • Full-text
  • PDF

• Technology Catalyst Forecast the Market for Drug Product

  Perspective: J Pharm Drug Deliv Res
  DOI:
  Christo Cimino
  
  • Abstract
  • Full-text
  • PDF

• Drug Substance is the Pure Fabric that Stimulates any Pharmacological Movement

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Susant Frad
  
  • Abstract
  • Full-text
  • PDF

• Curcumin has a tendency to be rapidly metabolized and isn't easily absorbed into the blood movement

  Commentary: J Pharm Drug Deliv Res
  DOI:
  Joseph Pant
  
  • Abstract
  • Full-text
  • PDF